Brian Cheng
Stock Analyst at J.P. Morgan
(3.26)
# 2,365
Out of 4,382 analysts
246
Total ratings
47.6%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintained: Buy | n/a | $149.23 | - | 12 | Jun 2, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | $26 | $16.43 | +58.25% | 1 | Jun 2, 2026 | |
| EIKN Eikon Therapeutics | Maintained: Buy | n/a | $8.96 | - | 4 | May 31, 2026 | |
| TGTX TG Therapeutics | Reiterated: Buy | n/a | $40.16 | - | 2 | May 27, 2026 | |
| IMVT Immunovant | Maintained: Buy | $35 → $47 | $31.11 | +51.08% | 11 | May 26, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $35 → $40 | $28.58 | +39.96% | 23 | May 26, 2026 | |
| TARA Protara Therapeutics | Maintained: Buy | $26 | $4.16 | +525.00% | 4 | May 18, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Sell | $8 | $13.54 | -40.92% | 17 | May 13, 2026 | |
| PTGX Protagonist Therapeutics | Maintained: Buy | $106 → $113 | $97.38 | +16.04% | 22 | May 13, 2026 | |
| KYTX Kyverna Therapeutics | Rated: Buy | $29 | $7.47 | +288.22% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $89 | $70.97 | +25.41% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $14 | $11.77 | +18.95% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $31 | $16.37 | +89.37% | 2 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $53.72 | +78.70% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $88 | $73.09 | +20.40% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.88 | - | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $46 | $17.20 | +167.44% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.40 | - | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.71 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $39 | $18.58 | +109.90% | 7 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.04 | - | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $67 | $51.84 | +29.24% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $125 | $74.13 | +68.62% | 4 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.15 | - | 2 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.44 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $6.40 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $3.58 | - | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.33 | n/a | 7 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.45 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.29 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $7.26 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.9654 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.175 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $3.5 | $1.50 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $8.41 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.9672 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $86 | $7.30 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.94 | n/a | 2 | Nov 2, 2021 |
Revolution Medicines
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $149.23
Upside: -
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $16.43
Upside: +58.25%
Eikon Therapeutics
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $8.96
Upside: -
TG Therapeutics
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $40.16
Upside: -
Immunovant
May 26, 2026
Maintained: Buy
Price Target: $35 → $47
Current: $31.11
Upside: +51.08%
Roivant Sciences
May 26, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $28.58
Upside: +39.96%
Protara Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $26
Current: $4.16
Upside: +525.00%
Intellia Therapeutics
May 13, 2026
Maintained: Sell
Price Target: $8
Current: $13.54
Upside: -40.92%
Protagonist Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $106 → $113
Current: $97.38
Upside: +16.04%
Kyverna Therapeutics
May 13, 2026
Rated: Buy
Price Target: $29
Current: $7.47
Upside: +288.22%
May 11, 2026
Maintained: Buy
Price Target: $80 → $89
Current: $70.97
Upside: +25.41%
May 11, 2026
Rated: Hold
Price Target: $13 → $14
Current: $11.77
Upside: +18.95%
May 11, 2026
Rated: Buy
Price Target: $30 → $31
Current: $16.37
Upside: +89.37%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $53.72
Upside: +78.70%
May 1, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $73.09
Upside: +20.40%
Apr 16, 2026
Upgraded: Hold
Price Target: n/a
Current: $1.88
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: $47 → $46
Current: $17.20
Upside: +167.44%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $29.40
Upside: -
Mar 13, 2026
Maintained: Sell
Price Target: n/a
Current: $2.71
Upside: -
Mar 4, 2026
Maintained: Buy
Price Target: $22 → $39
Current: $18.58
Upside: +109.90%
Mar 3, 2026
Maintained: Buy
Price Target: n/a
Current: $24.04
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $69 → $67
Current: $51.84
Upside: +29.24%
Dec 10, 2025
Reiterated: Buy
Price Target: $70 → $125
Current: $74.13
Upside: +68.62%
Dec 4, 2025
Reiterated: Sell
Price Target: n/a
Current: $1.15
Upside: -
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.44
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $6.40
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $3.58
Upside: -
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
Sep 13, 2024
Rated: Hold
Price Target: n/a
Current: $3.33
Upside: n/a
Jul 15, 2024
Maintained: Hold
Price Target: n/a
Current: $1.45
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.29
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $7.26
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.9654
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.175
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: $33 → $3.5
Current: $1.50
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $8.41
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.9672
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $93 → $86
Current: $7.30
Upside: n/a
Nov 2, 2021
Maintained: Buy
Price Target: $14
Current: $2.94
Upside: n/a